Atossa Therapeutics (ATOS) Divestments (2015)

Atossa Therapeutics (ATOS) posted quarterly Divestments of -$113883.0 for Q4 2015, down 241.33% quarter-over-quarter from $80578.0 in Q3 2015.

Atossa Therapeutics (ATOS) Divestments (2015) Analysis & Trends

Atossa Therapeutics (ATOS) has reported Divestments for 1 consecutive years, with -$113883.0 the latest figure, recorded in Q4 2015.

In Q4 2015, Divestments changed N/A year-over-year to -$113883.0; the TTM figure through Sep 2016 stood at -$113883.0 (changed N/A YoY), while the FY2015 annual figure was -$157684.0, up 53.44% from the prior year.
Divestments retreated to -$113883.0 in Q4 2015 per ATOS's latest filing, from $80578.0 in the prior quarter.
Across five years, Divestments topped out at $80578.0 in Q3 2015 and bottomed at -$113883.0 in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Vertex Pharmaceuticals	139.69 Bn	131.84 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.46 Bn	78.47 Bn	3.93 Bn	-
3	Argenx Se	65.62 Bn	60.44 Bn	1.37 Bn	-
4	Moderna	58.37 Bn	53.24 Bn	52.00 Mn	-
5	BeOne Medicines	42.17 Bn	37.07 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.73 Bn	28.43 Bn	992.69 Mn	-
7	BioNTech SE	28.27 Bn	9.87 Bn	668.28 Mn	-
8	Insmed	27.58 Bn	26.42 Bn	358.27 Mn	-
9	Royalty Pharma	27.23 Bn	26.40 Bn	-	-13.21 Mn
10	Atossa Therapeutics	23.25 Mn	23.25 Mn	-	-

Download Data